Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation

Genes and Development

Volumn 9, Issue 9, 1995, Pages 1046-1058

  Galaktionov, Konstantin ^a   Jessus, Catherine ^b,c   Beach, David ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b CNRS   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

Cdc25 phosphatase; cell cycle activation; Raf 1; Ras; signal transduction

Indexed keywords

CYCLIN DEPENDENT KINASE; PHOSPHATASE; RAS PROTEIN; THREONINE; TYROSINE;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL DIVISION; CELL GROWTH; CONTROLLED STUDY; DEPHOSPHORYLATION; EMBRYO; HELA CELL; HUMAN; HUMAN CELL; INSECT; MAMMAL; MEIOSIS; MITOGENESIS; MOUSE; NONHUMAN; ONCOGENE RAS; OOCYTE MATURATION; PRIORITY JOURNAL; PROTO ONCOGENE; SIGNAL TRANSDUCTION; SOMATIC CELL; XENOPUS LAEVIS;

ANIMALIA; ANURA; INSECTA; MAMMALIA; XENOPUS LAEVIS;

EID: 0029042689     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.9.9.1046     Document Type: Article

References (93)

1. Ahn, N.G., R. Seger, R.L. Bratlien, C.D. Diltz, N.K. Tonks, and E.G. Krebs. 1991. Multiple components in an epidermal growth factor-stimulated protein kinase cascade. In vitro activation of a myelin basic protein/microtubule-associated protein 2 kinase. J. Biol. Chem. 266: 4220-4227.
2. Cowley, S., H. Paterson, P. Kemp, and C.J. Marshall. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77: 841-852.
3. Dent, P., W. Haser, T.A.J. Haystead, L.A. Vincent, T.M. Robers, and T.W. Sturgill. 1992. Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro. Science 257: 1404-1407.
4. Draetta, G., H. Piwnica-Worms, D. Morrison, B. Druker, T. Roberts, and D. Beach. 1988. Human cdc2 protein kinase is a major cell-cycle regulated tyrosine kinase substrate. Nature 336: 738-744.
5. Dulic, V., W.K. Kaufmann, S.J. Wilson, T.D. Tlsty, E. Lees, J.W. Harper, S.J. Elledge, and S.I. Reed. 1994. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76: 1013-1023.
6. Dunphy, W.G. and A. Kumagai. 1991. The cdc25 protein contains an intrinsic phosphatase activity. Cell 67: 189-196.
7. Dunphy, W.G. and J.W. Newport. 1989. Fission yeast p13 blocks mitotic activation and tyrosine dephosphorylation of the Xenopus cdc2 protein kinase. Cell 58: 181-431.
8. El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
9. Evans, T., E.T. Rosenthal, J. Youngblom, D. Distel, and T. Hunt. 1983. Cyclin: A protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell 33: 389-396.
10. Fabian, J.R., D.K. Morrison, and I.O. Daar. 1993a. Requirement for Raf and MAP kinase function during the meiotic maturation of Xenopus oocytes. J. Cell Biol. 122: 645-652.
11. Fabian, J.R., I.O. Daar, and D.K. Morrison. 1993b. Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase. Mol. Cell Biol. 13: 7170-7173.
12. Featherstone, C. and P. Russell. 1991. Fission yeast p107wee1 mitotic inhibitor is a tyrosine/serine kinase. Nature 349: 808-811.
13. Freed, E., M. Symons, S.G. Macdonald, F. McCormick, and R. Ruggieri. 1994. Binding of 14-3-3 proteins to the protein kinase Raf and effects on its activation. Science 265: 1713-1716.
14. Fu, H., K. Xia, D.C. Pallas, C. Cui, K. Conroy, R.P. Narsimhan, H. Mamon, R.J. Collier, and T.M. Roberts. 1994. Interaction of the protein kinase Raf-1 with 14-3-3 proteins. Science 266: 126-129.
15. Galaktionov, K. and D. Beach. 1991. Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: Evidence for multiple roles of mitotic cyclins. Cell 67: 1181-1194.
16. Gautier, J., T. Matsukawa, P. Nurse, and J. Maller. 1989. Dephosphorylation and activation of Xenopus p34cdc2 protein kinase during the cell cycle. Nature 339: 626-629.
17. Gautier, J., M. Solomon, R. Booher, J. Bazan, and M. Kirshner. 1991. Cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell 67: 197-211.
18. Gomez, N. and P. Cohen. 1991. Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases. Nature 351: 69-72.
19. Gould, K. and P. Nurse. 1989. Tyrosine phosphorylation of the fission cdc2+ protein kinase regulates entry into mitosis. Nature 342: 39-45.
20. Gu, Y., J. Rosenblatt, and D.O. Morgan. 1992. Cell cycle regulation of cdk2 activity by phosphorylation of Thr160 and Tyr15. EMBO J. 11: 3995-4005.
21. Gu, Y., C.W. Turck, and D.O. Morgan. 1993. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366: 707-710.
22. Guan, K.-L., C.W. Jenkins, Y. Li, M. Nichols, X. Wu, C. O'Keefe, A.G. Matera, and Y. Xiong. 1994. Growth suppression by p18, a p16ink4/MTS1-and p14 ink4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes & Development. 8: 2939-2952.
23. Haccard, O., B. Sarcevic, A. Lewellyn, R. Hartley, L. Roy, T. Izumi, E. Erikson, and J.L. Maller. 1993. Induction of the metaphase arrest in cleaving Xenopus embryos by MAP kinase. Science 262: 1262-1265.
24. Hannon, G.J. and D. Beach. 1994. p15INK4B is a potential effector of TGF-β mediated cell cycle arrest. Nature 371: 257-261.
25. Harper, J.W., G.R. Adami, N. Wei, J. Keyomarsi, and S.J. Elledge. 1993. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
26. Heichman, K.A. and J. Roberts. 1994. Rules to replicate by. Cell 79: 557-562.
27. Heidecker, G., M. Huleihel, J.L. Cleveland, W. Kolch, T.W. Beck, P. Lloyd, T. Pawson, and U.R. Rapp. 1990. Mutational activation of c-raf-1 and definition of the minimal transforming sequence. Mol. Cell Biol 10: 2503-2512.
28. Heidecker, G., W. Kolch, D.K. Morrison, and U.R. Rapp. 1991. The role of Raf-1 phosphorylation in signal transduction. Adv. Cancer Res. 58: 53-73.
29. Herskowitz, I. 1995. MAP kinase pathways in yeast: For mating and more. Cell 80: 187-197.
30. Hibi, M., A. Lin, T. Smeal, A. Minden, and M. Karin. 1993. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes & Dev. 7: 2135-2148.
31. Hill, C.S. and R. Treisman. 1995. Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell 80: 199-211.
32. Hoffman, I., P.R. Clarke, M.J. Marcote, E. Karsenti, and G. Draetta. 1993. Phosphorylation and activation of human cdc25-C by cdc2/cyclin B and its involvement in the self-amplification of MPF at mitosis. EMBO J. 12: 53-63.
33. Hoffman, I., G. Draetta, and E. Karsenti. 1994. Activation of the phosphatase activity of human cdc25A by a cdk2-cyclinE dependent phosphorylation at the G1/S transition. EMBO J. 13: 4302-4310.
34. Howe, L. R., S.J. Leevers, N. Gomez, S. Nakielny, P. Cohen, and C.J. Marshall. 1992. Activation of the MAP kinase pathway by the protein kinase raf. Cell 71: 335-342.
35. Hunter, T. 1995. Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling. Cell 80: 225-236.
36. Hunter, T. and J. Pines. 1994. Cyclins and cancerII: CyclinD and cdk inhibitors come of age. Cell 79: 573-582.
37. Izumi, T. and J.L. Maller. 1991. Phosphorylation of Xenopus cyclins B1 and B2 is not required for cell cycle transitions. Mol. Cell Biol. 11: 3860-3867.
38. Izumi, T., D.H. Walker and J.L. Maller. 1992. Periodic changes in phosphorylation of the Xenopus cdc25 phosphatase regulate its activity. Mol. Cell Biol. 3: 1927-1939.
39. Jessus, C. and D. Beach. 1992. Oscillation of MPF is accompanied by periodic association between cdc25 and cdc2-cyclin B. Cell 68: 323-332.
40. Jessus, C., C. Thibier, and R. Ozon. 1987. Levels of microtubules during the meiotic maturation of the Xenopus oocyte. J. Cell Sci. 87: 705-712.
41. Jinno, S., K. Suto, A. Nagata, M. Igarashi, Y. Kanaoka, H. Nojima, and H. Okayama. 1994. Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J. 13: 1549-1556.
42. King, R.W., P.K. Jackson, and M.W. Kirshner. 1994. Mitosis in transition. Cell 79: 563-571.
43. Koff, A., F. Cross, A. Fisher, J. Schumacher, K. Leguallao, M. Phillippe, and J.M. Roberts. 1991. Human cyclin E, a new cyclin that interacts with two members of the cdc2 gene family. Cell 68: 1-20.
44. Kosako, H., Y. Gotoh, S. Matsuda, M. Ishikawa, and E. Nishida. 1992. Xenopus MAP kinase activator is a serine/threonine/ tyrosine kinase activated by threonine phosphorylation. EMBO J. 11: 2903-2908.
45. Krek, W. and E.A. Nigg. 1991. Mutations of p34cdc2 phosphorylation sites induce premature mitotic events in HeLa cells: Evidence of a double block to p34cdc2 kinase activation in vertebrates. EMBO J. 10: 3331-3341.
46. Kumagai, A. and W.G. Dunphy. 1992. Regulation of the cdc25 protein during the cell cycle in Xenopus extracts. Cell 70: 139-151.
47. Kyriakis, J.M., H. App, X.F. Zhang, P. Banerjee, D.L. Brautigan, U.R. Rapp, and J. Avruch. 1992. Raf-1 activates Map kinase-kinase. Nature 358: 417-421.
48. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685
49. Lange-Carter, C.A. and G.L. Johnson. 1994. Ras-dependent growth factor regulation of MEK kinase in PC12 cells. Science 265: 1458-1461.
50. Leevers, S.J., F.G. Paterson, and C.J. Marshall. 1994. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 369: 411-414.
51. Lew, D.J., V. Dulic, and S.I. Reed. 1991. Isolation of three novel human cyclins by rescue of G1 cyclin (cln) function in yeast. Cell 66: 1197-1206
52. Lundgren, K., N. Walworth, R. Booher, M. Dembski, M. Kirschner, and D. Beach. 1991. Mik1 and wee1 cooperate in the inhibitory tyrosine phosphorylation of cdc2. Cell 64: 1111-1122.
53. Marshall, C.J. 1995. Specificity of receptor tyrosine kinse signalling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185.
54. Matsushime, H., M.F. Roussel, R.A. Ashmun, and C.J. Sherr. 1991. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65: 701-713.
55. Meyerson, M., G.H. Enders, C.-L. Wu, L.-K. Su, C. Gorka, C. Neilson, E. Harlow, and L.-H. Tsai. 1992. A family of human cdc2-related protein kinases. EMBO J. 11: 2909-2917.
56. Millar, J.B., C.H. McGowan, G. Lenaers, R. Jones, and P. Russell. 1991. p80cdc25 mitotic inducer is the tyrosine phosphatase that activates p34cdc2 kinase in fission yeast. EMBO J. 10: 4301-4309.
57. Minden, A., M. McMahon, C. Lange-Carter, B. Derijard, R.J. Davis, G.L. Johnson, and M. Karin. 1994. Differential activation of ERK and JNK MAP kinases by Raf-1 and MEKK. Science 266: 1719-1723.
58. Moria, A.O., G. Draetta, D. Beach, and J.Y. Wang. 1989. Reversible tyrosine phosphorylation of cdc2: Dephosphorylation accompanies activation during entry into mitosis. Cell 58: 193-203.
59. Muslin, A.J., A.M. MacNicol, and L.T. Williams. 1993. Raf-1 protein kinase is important for progesterone-induced Xenopus oocyte maturation and acts downstream of mos. Mol. Cell. Biol. 13: 4197-4202.
60. Nagata, A., M. Igarashi, S. Jinno, K. Suto, and H. Okayama. 1991. An additional homolog of the fission yeast cdc25+ gene occurs in humans and is highly expressed in some cancer cells. New Biol. 3: 959-968.
61. Noda, A., Y. Ning, S.F. Venable, O.M. Pereira-Smith, and J.R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211: 90-98.
62. Parker, L.L., S. Atherton-Fessler, M.S. Lee, S. Ogg, J.L. Falk, K.I. Swenson, and H. Piwnica-Worms. 1991. Cyclin promotes the tyrosine phosphorylation of p34cdc2 in a wee1+dependent manner. EMBO J. 10: 1255-1263.
63. Parker, L., S. Atherton-Fessler, and H. Piwnica-Worms. 1992. p107wee1 is a dual-specificity kinase that phosphorylates p34cdc2 on tyrosine 15. Proc. Natl. Acad. Sci. 89: 2917-2921.
64. Polyak, K., M.H. Lee, H. Erdjument-Bromage, A. Koff, J.M. Roberts, P. Tempst, and J. Massague. 1994a. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66.
65. Polyak, K., J.Y. Kato, M.J. Solomon, C.J. Sherr, J. Massague, J.M. Roberts, and A. Koff. 1994b. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes & Dev. 8: 9-22.
66. Rapp, U.R., G. Heidecker, M. Huleihel, J.L. Cleveland, W.C. Choi, T. Pawson, J.N. Ihle, and W.B. Anderson. 1988. Raf family serine/threonine protein kinases in mitogenic signal transduction. Cold Spring Harbor Symp. Quant. Biol. 53: 173-184.
67. Rodriguez-Viciana, P., P.H. Warne, R. Dhand, B. Vanhaesebroeck, I. Gout, M.J. Fry, M.D. Waterfield, and J. Downward. 1994. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370: 527-532.
68. Rossow, P.W., V.G.H. Riddle, and A.B. Pardee. 1979. Synthesis of labile, serum-dependent protein in early G1 controls animal cell growth. Proc. Natl. Acad. Sci. 76: 4446-4450.
69. Russell, P. and P. Nurse. 1986. cdc25+ functions as an inducer in the mitotic control of fission yeast. Cell 45: 145-153.
70. _. 1987. Negative regulation of mitosis by wee1+, a gene encoding a protein kinase homolog. Cell 49: 559-567.
71. Sadhu, K., S.I. Reed, H. Richardson, and P. Russell. 1990. Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2. Proc. Natl. Acad. Sci. 87: 5139-5143.
72. 59] Ha-ras protein. J. Biol. Chem. 264: 856-861.
73. Sanchez, I., R.T. Hughes, B.J. Mayer, K. Yee, J.R. Woodgett, J. Avruch, J.M. Kyriakis, and L.I. Zon. 1994. Role of SAPK/ ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 372: 794-798.
74. Serrano, M., G. Hannon, and D. Beach. 1993. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707.
75. Sherr, C.J. 1994. G1-phase progression: cycling on cue. Cell 79: 817-825.
76. Solomon, M., T. Lee, and M. Kirschner. 1992. The role of phosphorylation in p34cdk2 activation: Identification of an activating kinase. Mol. Biol. Cell 3: 13-27.
77. Stacey, D.W., M. Roudebush, R. Day, S.D. Mosser, J.B. Gibbs, and L.A. Feig. 1991. Dominant inhibitory Ras mutants demonstrate the requirement for Ras activity in the action of tyrosine kinase oncogenes. Oncogene 6: 2297-2304.
78. Stanton, V.P. Jr., D.W. Nichols, A.P. Laudano, and G.M. Cooper. 1989. Definition of the human raf amino-terminal regulatory region by deletion mutagenesis. Mol. Cell Biol. 9: 639-647.
79. Stokoe, D., S.G. Macdonald, K. Cadwallader, M. Symons, and J.F. Hancock. 1994. Activation of Raf as a result of recruitment to the plasma membrane. Science 264: 1463-1467.
80. Strausfeld, U., J.C. Labbe, D. Fesquet, J.C. Cavadore, A. Picard, K. Sadhu, P. Russell, and M. Doree. 1991. Dephosphorylation and activation of a p34cdc2 cyclin-B complex in vitro by human cdc25 protein. Nature 351: 242-245.
81. Swenson, K.I., K.M. Farrell, and J.V. Ruderman. 1986. The clam embryo protein cyclin A induces entry into M phase and the resumption of meiosis in Xenopus oocytes. Cell 47: 861-870.
82. Thomas, S.M., M. DeMarco, G. D'Arcangelo, S. Halegoua, and J.S. Brugge. 1992. Ras is essential for nerve growth factor-and phorbol ester-induced tyrosine phosphorylation of MAP kinases. Cell 68: 1031-1040.
83. Toyoshima, H. and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78: 67-74.
84. Traverse, S., P. Cohen, H. Paterson, C. Marshall, U. Rapp, and R.J. Grand. 1993. Specific association of activated MAP kinase kinase kinase (Raf) with the plasma membranes of ras-transformed retinal cells. Oncogene 8: 3175-3181.
85. van Aelst, L., M. Barr, S. Marcus, A. Polverino, and M. Wigler. 1993. Complex formation between RAS and RAF and other protein kinases. Proc. Natl. Acad. Sci. 90: 6213-6217.
86. Wartmann, M. and R.J. Davis. 1994. The native structure of the activated Raf protein kinase is a membrane-bound multi-subunit complex. J. Biol. Chem. 269: 6695-6701.
87. src are required, but neither alone is sufficient, to activate the Raf-1 kinase. Proc. Natl. Acad. Sci. 89: 2922-2926.
88. Williams, N.G., H. Paradis, S. Agarwal, D.L. Charest, S.L. Pelech, and T.M. Roberts. 1993. Raf-1 and p21v-ras cooperate in the activation of mitogen-activated protein kinase. Proc. Natl. Acad. Sci. 90: 5772-5776.
89. Won, K.A., Y. Xiong, D. Beach, and M.Z. Gilman. 1992. Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc. Natl. Acad. Sci. 89: 9910-9914.
90. Wood, K.W., C. Sarnecki, T.M. Roberts, and J. Blenis. 1992. Ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell 68: 1041-1050.
91. Xiong, Y., T. Connolly, B. Futcher, and D. Beach. 1991. Human D-type cyclin. Cell 65: 691-699.
92. Xiong, Y., G. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
93. Yan, M., T. Dai, J.C. Deak, J.M. Kyriakis, L.I. Zon, J.R. Woodgett, and D.J. Templeton. 1994. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator, SEK1. Nature 370: 798-801.